The expression of APOL1 was prevalently upregulated in several cancers, including head and neck squamous cell carcinoma 58, papillary thyroid carcinoma 59, small cell lung carcinoma 60, hepatocellular carcinoma 61, pancreatic cancer 57, and bladder cancer 62. This evidence concerns the gene APOL1 and pancreatic neoplasm.